Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Blood Reviews|June 24, 2022
Determinants of severity in sickle cell diseaseDavid C Rees, Valentine A M Brousse, John N BrewinExpert Opinion on Investigational Drugs|June 1, 2017
Prasugrel hydrochloride for the treatment of sickle cell diseaseNicola Conran, David C ReesExpert Review of Hematology|August 2, 2011
The safety and efficacy of hydroxycarbamide in infants with sickle cell anemiaClare Wykes, David C ReesBritish Journal of Haematology|July 1, 2026
Methaemoglobinaemia: From pathophysiology to contemporary clinical managementAlexander J Twine, David C ReesNature Chemistry|March 8, 2011
The rise of fragment-based drug discoveryChristopher W Murray, David C ReesExpert Opinion on Therapeutic Targets|February 21, 2023
Emerging drug targets for sickle cell disease: shedding light on new knowledge and advances at the molecular levelJohn S Gibson, David C ReesJournal of Inherited Metabolic Disease|June 23, 2010
A retrospective analysis of outcome of pregnancy in patients with acute porphyriaJoanne T Marsden, David C ReesJournal of Clinical Pathology|August 3, 2013
Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyriaJoanne T Marsden, David C ReesBritish Journal of Haematology|November 30, 2011
Biomarkers in sickle cell diseaseDavid C Rees, John S GibsonPageof 14